Survey on the future organisation of first-trimester ultrasound screening in Flanders, Belgium [2]

Prenatal Diagnosis

Volumn 25, Issue 6, 2005, Pages 518-519

  Gyselaers, Wilfried ^a   De Catte, Luc ^b   Witters, Ingrid ^c   De Jonge, Eric ^a   Ombelet, Willem ^a   Nijhuis, Jan ^d  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; BELGIUM; DIAGNOSTIC ACCURACY; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; LETTER; MEDICAL SERVICE; OBSERVER VARIATION; OBSTETRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING TEST; TRAINING;

BELGIUM; FEMALE; GESTATIONAL AGE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; QUESTIONNAIRES; ULTRASONOGRAPHY, PRENATAL;

EID: 21844464354     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1137     Document Type: Letter

References (10)

1. Benn PA. 2002. Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions. Clin Chim Acta 324: 1-11.
2. Cuckle H, Wald N. 2000. Principles of screening: tests using single markers. In Antenatal and Neonatal Screening. Wald N, Leck I (eds). Oxford University Press: Oxford; 3-22.
3. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. 2002. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol 187: 1230-1234.
4. Kind en Gezin. 2004. The Child in Flanders, 2003. Kind en Gezin: Brussels. http://www.kindengezin.be/Algemeen/Over_Kind_En_Gezin/Jaarverslagen/ default.jsp (10-8-2004).
5. Monni G, Zoppi MA, Ibba RM, Floris M. 1997. Fetal nuchal translucency test for Down's syndrome. Lancet 350: 1631-1632.
6. Nicolaides KH. 2003. Screening for chromosomal defects. Ultrasound Obstet Gynecol 21: 313-321.
7. Pajkrt E, Mol BW, Boer K, Drogtrop AP, Bossuyt PM, Bilardo CM. 2000. Intra- and interoperator repeatability of the nuchal translucency measurement. Ultrasound Obstet Gynecol 15: 297-301.
8. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 10: 56-104.
9. Welch KK, Malone FD. 2003. Nuchal translucency-based screening. Clin Obstet Gynecol 46: 909-922.
10. Whittle M. 2001. Down's syndrome screening: where to now? BJOG 108: 559-561.